Gately L, McLachlan S, Dowling A, Philip J (2017) Life beyond a diagnosis of glioblastoma: a systematic review of the literature. J Cancer Surviv 11:447–452

Article  CAS  PubMed  Google Scholar 

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

Article  CAS  PubMed  Google Scholar 

de Souza RM, Shaweis H, Han C, Sivasubramiam V, Brazil L, Beaney R, Sadler G, Al-Sarraj S, Hampton T, Logan J, Hurwitz V, Bhangoo R, Gullan R, Ashkan K (2016) Has the survival of patients with glioblastoma changed over the years? Br J Cancer 114:146–150

Article  Google Scholar 

Henriksson R, Asklund T, Poulsen HS (2011) Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review. J Neurooncol 104:639–646

Article  CAS  PubMed  PubMed Central  Google Scholar 

Witzmann K, Raschke F, Troost EGC (2021) MR image changes of normal-appearing brain tissue after radiotherapy. Cancers 13:1573

Article  CAS  PubMed  PubMed Central  Google Scholar 

Armocida D, Pesce A, Di Giammarco F, Frati A, Santoro A, Salvati M (2019) Long term survival in patients suffering from glio-blastoma multiforme: a single-center observational cohort study. Diagnostics 9:209

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pazzaglia S, Briganti G, Mancuso M, Saran A (2020) Neurocognitive decline following radiotherapy: mechanisms and therapeutic implications. Cancers 12:146

Article  CAS  PubMed  PubMed Central  Google Scholar 

Makale MT, McDonald CR, Hattangadi-Gluth J, Kesari S (2017) Brain irradiation and long-term cognitive disability: current concepts. Nat Rev Neurol 13:52–64

Article  CAS  PubMed  Google Scholar 

Sharma P, Medhi PP, Kalita AK, Bhattacharyya M, Nath J, Sarma G, Yanthan Y (2023) Factors associated with neurocognitive impairment following chemoradiotherapy in patients with high-grade glioma: results of a prospective trial. Brain Tumor Res Treat 11:183–190

Article  PubMed  PubMed Central  Google Scholar 

Wefel J, Pugh S, Choucair A, Fisher B, Fox S, Meyers C, Ashby L, Mikkelsen T, Glass J, Yu M, Howard S, Movsas B, Mehta M (2019) NCOG-01. Neurocognitive function (NCF) and quality of life (QOL) results from a phase ii study of temozolomide-based chemoradiotherapy regimen for high risk low-grade gliomas. Neuro-Oncol 21:158–159

Article  Google Scholar 

Saito K, Mukasa A, Narita Y, Tabei Y, Shinoura N, Shibui S, Saito N (2014) Toxicity and outcome of radiotherapy with concomitant and adjuvant temozolomide in elderly patients with glioblastoma: a retrospective study. Neurol Med Chir (Tokyo) 54:272–279

Article  PubMed  Google Scholar 

Kevin Suen K-F, Tat Ming Chan D, Ho-Fung Loong H, Wong CWK, Yeung WME, Lam CMD, Chi-Ping NGS, Hsieh YPS, Lau KYC, Chan YFY, Fook SMS, Sang Poon W (2021) Health-related quality of life of glioblastoma patients receiving post-operative concomitant chemoradiotherapy plus adjuvant chemotherapy: a longitudinal study. Interdiscip Neurosurg 26:101339

Article  Google Scholar 

Wang Q, Xiao F, Qi F, Song X, Yu Y (2020) Risk factors for cognitive impairment in high-grade glioma patients treated with postoperative radiochemotherapy. Cancer Res Treat Off J Korean Cancer Assoc 52:586

CAS  Google Scholar 

Ribi K, Relly C, Landolt MA, Alber FD, Boltshauser E, Grotzer MA (2005) Outcome of medulloblastoma in children: long-term complications and quality of life. Neuropediatrics 36:357–365

Article  CAS  PubMed  Google Scholar 

Cayuela N, Jaramillo-Jiménez E, Càmara E, Majós C, Vidal N, Lucas A, Gil-Gil M, Graus F, Bruna J, Simó M (2019) Cognitive and brain structural changes in long-term oligodendroglial tumor survivors. Neuro-Oncol 21:1470–1479

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nagtegaal SHJ, David S, Philippens MEP, Snijders TJ, Leemans A, Verhoeff JJC (2021) Dose-dependent volume loss in subcortical deep grey matter structures after cranial radiotherapy. Clin Transl Radiat Oncol 26:35–41

CAS  PubMed  Google Scholar 

Li X, Chen H, Lv Y, Chao HH, Gong L, Li C-SR, Cheng H (2018) Diminished gray matter density mediates chemotherapy dosage-related cognitive impairment in breast cancer patients. Sci Rep 8:13801

Article  PubMed  PubMed Central  Google Scholar 

Huynh-Le M-P, Karunamuni R, Moiseenko V, Farid N, McDonald CR, Hattangadi-Gluth JA, Seibert TM (2019) Dose-dependent atrophy of the amygdala after radiotherapy. Radiother Oncol 136:44–49

Article  PubMed  PubMed Central  Google Scholar 

Nagtegaal SHJ, David S, van Grinsven EE, van Zandvoort MJE, Seravalli E, Snijders TJ, Philippens MEP, Verhoeff JJC (2021) Morphological changes after cranial fractionated photon radiotherapy: localized loss of white matter and grey matter volume with increasing dose. Clin Transl Radiat Oncol 31:14–20

CAS  PubMed  PubMed Central  Google Scholar 

Gommlich A, Raschke F, Petr J, Seidlitz A, Jentsch C, Platzek I, van den Hoff J, Kotzerke J, Beuthien-Baumann B, Baumann M, Krause M, Troost EGC (2022) Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapy. Magn Reson Mater Phys Biol Med 35:145–152

Article  CAS  Google Scholar 

Karunamuni R, Bartsch H, White NS, Moiseenko V, Carmona R, Marshall D, Seibert TM, McDonald CR, Farid N, Krishnan A, Kuperman J, Mell L, Brewer JB, Dale AM, Hattangadi-Gluth JA (2016) Dose-dependent cortical thinning after partial brain radiation in high-grade glioma. Int J Radiat Oncol Biol Phys 94:297–304

Article  PubMed  Google Scholar 

Jenkinson M, Beckmann CF, Behrens TEJ, Woolrich MW, Smith SM (2012) FSL. NeuroImage 62:782–790

Article  PubMed  Google Scholar 

Gaser C, Dahnke R, Thompson PM, Kurth F, Luders E, Initiative ADN (2023) CAT – A Computational Anatomy Toolbox for the Analysis of Structural MRI Data. 2022.06.11.495736.

Woolrich MW, Jbabdi S, Patenaude B, Chappell M, Makni S, Behrens T, Beckmann C, Jenkinson M, Smith SM (2009) Bayesian analysis of neuroimaging data in FSL. Neuroimage 45:S173–S186

Article  PubMed  Google Scholar 

Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23:S208–S219

Article  PubMed  Google Scholar 

Zhang Y, Brady M, Smith S (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20:45–57

Article  CAS  PubMed  Google Scholar 

Manjón JV, Coupé P, Martí-Bonmatí L, Collins DL, Robles M (2010) Adaptive non-local means denoising of MR images with spatially varying noise levels. J Magn Reson Imaging 31:192–203

Article  PubMed  Google Scholar 

Rajapakse JC, Giedd JN, Rapoport JL (1997) Statistical approach to segmentation of single-channel cerebral MR images. IEEE Trans Med Imaging 16:176–186

Article  CAS  PubMed  Google Scholar 

Giorgio A, De Stefano N (2013) Clinical use of brain volumetry. J Magn Reson Imaging 37:1–14

Article  PubMed  Google Scholar 

Gommlich A, Raschke F, Wahl H, Troost EGC (2018) Retrospective assessment of MRI-based volumetric changes of normal tissues in glioma patients following radio(chemo)therapy. Clin Transl Radiat Oncol 8:17–21

PubMed  Google Scholar 

de Groot JD, van Dijken BRJ, van der Weide HL, Enting RH, van der Hoorn A (2023) Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients. PLoS ONE 18:e0275077

Article  PubMed  PubMed Central  Google Scholar 

Prust MJ, Jafari-Khouzani K, Kalpathy-Cramer J, Polaskova P, Batchelor TT, Gerstner ER, Dietrich J (2015) Standard chemoradiation for glioblastoma results in progressive brain volume loss. Neurology 85:683–691

Article  CAS  PubMed  PubMed Central